Exercise priming to enhance therapeutic bond and behavioral activation in CBT for MDD: a randomized controlled target-engagement trial with remission signal
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2026.121606 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Jacob D Meyer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology, University of Wisconsin-Madison, Madison, WI, USA; Department of Kinesiology, Iowa State University, Ames, IA, USA. Electr…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Cognitive Behavioral Therapy, Therapeutic Alliance, Exercise Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCCIH NIH HHS, NIMH NIH HHS, National Center for Complementary and Integrative Health.
Abstract (Originalsprache)
Major depressive disorder (MDD) is a debilitating condition with frequent relapses. Augmentation strategies may improve psychotherapy outcomes, particularly if they enhance mechanisms of change. Using an experimental therapeutics approach, this pilot trial evaluated whether 30 min of individual moderate exercise immediately before individual cognitive behavioral therapy (ActiveCBT) engages two mechanistic targets (behavioral activation and therapeutic alliance) compared to a time- and attention-matched control (CalmCBT). Forty adults with DSM-5 MDD were severity-stratified and randomized to 8 weeks of ActiveCBT (n = 19) or CalmCBT (n = 21). Primary outcomes were the Working Alliance Inventory-Short Revised (WAI; Bond, Task, Goals subscales) and Behavioral Activation for Depression Scale (BADS). Depression outcomes included Hamilton Rating Scale for Depression (HAMD) response (≥50% reduction) and remission (HAMD
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Kinesiology, University of Wisconsin-Madison, Madison, WI, USA; Department of Kinesiology, Iowa State University, Ames, IA, USA. Electronic address: jdmeyer3@wisc.edu.
- Department of Kinesiology, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Kinesiology, Iowa State University, Ames, IA, USA.
- Department of Psychological and Brain Sciences, University of Iowa, Iowa City, IA, USA.
- Department of Counseling Psychology, University of Wisconsin-Madison, Madison, WI, USA; Center for Healthy Minds, University of Wisconsin-Madison, Madison, WI, USA.
- Center for Healthy Minds, University of Wisconsin-Madison, Madison, WI, USA.
Förderung
- NCCIH NIH HHS
- NIMH NIH HHS
- National Center for Complementary and Integrative Health
- National Institute of Mental Health
Zitieren
APA
Meyer, J. D., Kelly, S. J. E., Gidley, J. M., Lansing, J. E., Smith, S. L., Churchill, S. L., Connolly, M. L., Thomas, E. B. K., Goldberg, S. B., Abercrombie, H. C., Murray, T. A., & Wade, N. G. (2026). Exercise priming to enhance therapeutic bond and behavioral activation in CBT for MDD: a randomized controlled target-engagement trial with remission signal. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2026.121606
Vancouver
Meyer JD, Kelly SJE, Gidley JM, Lansing JE, Smith SL, Churchill SL, et al. Exercise priming to enhance therapeutic bond and behavioral activation in CBT for MDD: a randomized controlled target-engagement trial with remission signal. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2026.121606
BibTeX
@article{Meyer2026,
author = {Meyer, Jacob D and Kelly, Shania J E and Gidley, John M and Lansing, Jeni E and Smith, Seana L and Churchill, Sydney L and Connolly, Madeleine L and Thomas, Emily B K and Goldberg, Simon B and Abercrombie, Heather C and Murray, Thomas A and Wade, Nathaniel G},
title = {Exercise priming to enhance therapeutic bond and behavioral activation in CBT for MDD: a randomized controlled target-engagement trial with remission signal},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2026.121606}
}
EUVIMED